Vaccines | CHOP Research Institute

Featured Research Trainee: Q&A With Amarachi Onwuka

Published on

Apr 3, 2024

Featured Research Trainee: Q&A With Amarachi Onwuka

Celebrate Diversity Month this April with Ama Onwuka, who shares her insight on how diversity impacts scientific breakthroughs.

CHOP Named One of the Best Children’s Hospitals in the Nation

Published on

Jun 23, 2023

in Cornerstone Blog

In the News: CHOP Named One of the Best Children’s Hospitals in the Nation

U.S. News & World Report ranks CHOP No. 1 in region, and we’re proud to have eight specialties ranked in the top five.

DoSES

This research is studying a vaccine against Mpox (formerly known as monkeypox) that is FDA approved for adults but not yet approved for children.

Our Best Stories of 2021, From Self-Care to Setting New Standards for Pediatric Research

Published on

Dec 30, 2021

in Cornerstone Blog

Here’s our list of the 2021 Cornerstone stories our social media followers engaged with the most.

Faculty Spotlight: Discussing Mentorship and mRNA With Paul Offit, MD

Published on

Nov 10, 2021

in Cornerstone Blog

Discussing Mentorship and mRNA With Paul Offit, MD

Our Faculty Spotlight features Paul Offit, MD, director of the Vaccine Education Center at CHOP.

Ma Laboratory for Immune Engineering

Our lab designs novel genetic, chemistry and engineering tools to dissect immune cell-cell and cell-tissue crosstalk and leverages these crosstalk mechanisms to develop biomaterials, protein, and cell-based precision immunotherapies.

Leyuan Ma, PhD

Dr. Ma focuses on immune engineering. He leverages genetic, chemistry, and engineering tools to dissect immune cell-cell and cell-tissue crosstalk and harness these crosstalk mechanisms to develop biomaterials, protein, and cell-based precision immunotherapies for cancer and autoimmune diseases.

E-mail:

mal5 [at] chop.edu

From Mutations to Mask Mandates, New Insights Into SARS COV-2 Diversity

Published on

May 3, 2021

in Cornerstone Blog

New Insights Into SARS COV-2 Viral Diversity

New research suggests an association between the number of SARS COV-2 variants and the implementation of mask mandates in different states.

NICU RISE (Rotavirus Immunization Safety Evaluation)

This observational cohort study aims to estimate the rate of transmission of vaccine-strain rotavirus from vaccinated to unvaccinated infants.

Vaccine and Treatment Evaluation Unit

Children’s Hospital of Philadelphia has partnered with Vanderbilt University Medical Center as a subsidiary of the Vaccine and Treatment Evaluation Unit (VTEU). NIAID established the VTEUs in 1962 as a ready resource for conducting clinical trials of vaccines and treatments for infectious diseases.